An observational study in Acne Vulgaris, sponsored by Sohag University. Status unknown at 1 site in Egypt. Open to participants aged 5 Days to 35 Years. Per ClinicalTrials.gov, last updated 2021-09-29.
Sponsored by Sohag University · Observational
The Global Burden of Disease Study 2010 found that acne vulgaris is the eight most common skin disease, with an estimated global prevalence (for all ages) of 9.38%.(1) Furthermore . Acne is a chronic inflammatory process that presents with two types of lesions clinically; non-inflammatory (closed and open) and inflammatory lesions (papules ,pustules ,nodules and post inflammatory pigmentary changes).
730 studies on the registry are indexed under Acne Vulgaris; 86 are open to participants now.
This study's planned enrollment of 150 is above the median of 90 across 81 observational studies indexed under Acne Vulgaris.
Browse Acne Vulgaris studies →Sohag University is the lead sponsor of 1,183 studies on the registry; 612 are open to participants now.
Counted across the registry records on this site, refreshed daily.
The study will be designed as cross-sectional hospital based study. will include patients of both sexes of any age with clinical evident acne vulgaris who will attend Outpatient Clinics of Dermatology, Venerology and Andrology, Faculty of Medicine, Sohag University Hospitals
Exclusion Criteria:
Body mass index
(weight (kg)/height(m)2)
Time frame: one year
severity of acne vulgaris
Global acne grading system (GAGS): The GAGS is an acne grading system developed by Doshi et al . (13) In this grading system, lesions of acne vulgaris are divided into six sites: the forehead, right cheek, left cheek, nose, chin, and chest back.Each site has one factor score: the chin and nose are graded by one factor, the forehead and each cheek are graded by two factors and the chest and back are graded by three factors. Lesions are scored as follows: one point for a comedone, two points for a papule, three points for a pustule, and four points for a nodule. The lesion score of each site is calculated by the factor score, and the final score for that site is obtained. The total score varies between 1 and 44 and is evaluated as follows: mild falls between 1 and 18, moderate falls between 19 and 30, severe falls between 31 and 38, and very severe is over 39.
Time frame: One year
This study is status unknown, as verified in Sep 2021. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Sohag University